The trajectory of Viagra, initially marketed by copyright, presents a fascinating case study for backers considering the pharmaceutical arena . While its early success and creation of billions in revenue , the patent end has opened the floodgates for generic medications, significantly reducing income potential . This shift raises concerns about the